Streetbeat News

Earnings

ASRT

Assertio Holdings Inc (ASRT) shares are trading higher by 12.48% after the company reported Q2 financial results and withdrew its 2023 financial outlook due to the recent approval of a generic indomethacin suppository by the U.S. FDA. Zydus Lifesciences Limited received the approval and has been granted a CGT designation and 180-day CGT exclusivity to market the product.

Portfolio Pulse from Henry Khederian

August 07, 2023 | 2:09 pm

BNGO

Bionano Genomics, Inc. (NASDAQ:BNGO) shares are trading lower after the company commenced trading on a 1-for-10 reverse stock split-adjusted basis. The company's shares are moving lower on above-average trading volume with more than 660,000 shares traded compared to the 100-day average of 1.04 million shares. Bionano Genomics is expected to release its Q2 financial reports on Wednesday, with an expected loss of 10 cents per share and revenue of $8.29 million.

Portfolio Pulse from Erica Kollmann

August 07, 2023 | 2:08 pm

KSCP

Knightscope, Inc. (NASDAQ:KSCP), a developer of autonomous security robots and blue light emergency communication systems, announced its Second Quarter Town Hall Update will be held on Monday, August 14, 2023. The company will share current events and 2023 financial highlights following the filing of its 10-Q update with the U.S. Securities and Exchange Commission. The event will include a pre-recorded video update on Q2 2023 performance metrics and a live Q&A session.

Portfolio Pulse from Happy Mohamed

August 07, 2023 | 2:04 pm

HSIC

Henry Schein Inc (NASDAQ:HSIC) reported Q2 FY23 sales of $3.10 billion, slightly below the consensus of $3.11 billion, but up 2.3% Y/Y. Sales of PPE products and COVID-19 test kits were $163 million, a decrease of $96 million versus the prior-year period. Global Dental sales were $2.0 billion, up 5.6% Y/Y, while Global Medical sales were $1.0 billion, down 4.6% Y/Y. The company reaffirmed its FY23 adjusted EPS outlook of $5.18-$5.35, compared to the consensus of $5.27. HSIC stock is down 3.19% at $75.60.

Portfolio Pulse from Vandana Singh

August 07, 2023 | 2:03 pm

ALE

ALLETE (NYSE:ALE) is set to release its quarterly earnings report on Tuesday, 2023-08-08, with analysts estimating an EPS of $0.78. The company's past performance shows a pattern of share price changes following earnings announcements. The company's shares were trading at $55.76 as of August 04, with a 10.47% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:02 pm

NFE

New Fortress Energy (NASDAQ:NFE) is set to release its quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an EPS of $0.56. The company's past performance shows a trend of beating EPS estimates, which often leads to a share price increase. However, the stock has been on a downward trend, with shares down 48.98% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:02 pm

ATKR

Atkore (NYSE:ATKR) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08, with analysts estimating an EPS of $4.26. The company's past performance shows a pattern of share price drops following earnings beats. Shares of Atkore were trading at $151.17 as of August 04, with a 70.73% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:02 pm

HAE

Haemonetics (NYSE:HAE) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.76. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $89.84 and has seen a 33.06% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:01 pm

RVMD

Revolution Medicines (NASDAQ:RVMD) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.81. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $31.21 and has seen a 30.01% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:01 pm

AZTA

Azenta (NASDAQ:AZTA) is set to release its quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an EPS of $-0.02. Last quarter, the company missed EPS by $0.04, resulting in an 18.89% drop in share price. Shares of Azenta were trading at $47.54 as of August 04, with a 52-week return of -26.08%.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:01 pm